Biphasic insulin aspart Prescribing at SAFFRON GROUP PRACTICE
Drugs used in diabetes | Endocrine System
Items (12m)
346
Total Quantity
4,232
NHS Cost
£25.0K
vs National Avg
+240.8%
SAFFRON GROUP PRACTICE prescribed 346 items of Biphasic insulin aspart over the last 12 months at a cost of £25,044 to the NHS. This is 240.8% above the national average prescribing rate. Biphasic insulin aspart is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
38
Jun 2026
40
Jun 2026
29
Jun 2026
29
Jun 2026
28
Jun 2026
34
Jun 2026
23
Jun 2026
30
Jun 2026
24
Jun 2026
29
Jun 2026
19
Jun 2026
23
Prescribing Details
| Total Items | 346 |
|---|---|
| Total Quantity | 4,232 |
| Total NHS Cost | £25,044 |
| Presentations | 2 different forms |
| vs National Average | +240.8% |
Biphasic insulin aspart Prescribing Comparison
| This practice | 346 items |
|---|---|
| National average per practice | 102 items |
| Difference | +240.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.